Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation

BACKGROUND: Shikonin (SKN), a naphthoquinone compound, is isolated from Chinese herbal medicine Lithospermum root and has been studied as an anticancer drug candidate in human tumor models. This study is designed to investigate whether SKN can sensitize the therapeutic effect of paclitaxel (PTX) in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chin Med
Main Authors: Wang, Zhu, Yin, Jianhua, Li, Mingxing, Shen, Jing, Xiao, Zhangang, Zhao, Yueshui, Huang, Chengliang, Zhang, Hanyu, Zhang, Zhuo, Cho, Chi Hin, Wu, Xu
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6417206/
https://ncbi.nlm.nih.gov/pubmed/30911326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13020-019-0231-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares